世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州心電計（ECG）市場の展望、2028年


Europe Electrocardiograph (ECG) Market Outlook, 2028

ヨーロッパでは心臓専門医は心電図（ECG）を用いて、電気的活動が速いか、不規則か、正常かを評価する。心臓の構成要素が大きくなりすぎているか、働きすぎているかを判断するために、心筋を流れる電気活動の量を... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Bonafide Research & Marketing Pvt. Ltd.
ボナファイドリサーチ 		2023年11月30日 US$3,450
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		96 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

ヨーロッパでは心臓専門医は心電図（ECG）を用いて、電気的活動が速いか、不規則か、正常かを評価する。心臓の構成要素が大きくなりすぎているか、働きすぎているかを判断するために、心筋を流れる電気活動の量をモニターするためにも使用されます。心電図（ECG）は、心拍の電気的活動を経時的に記録する非侵襲的な医療検査である。心拍のたびに電気インパルスが発生し、電極を使用して捕捉される。電極は、心拍のたびに心筋が脱分極することによって生じる、皮膚のわずかな電気的変動さえも拾い上げる。世界保健機関（WHO）によると、ヨーロッパでは心血管系疾患が死因の大半を占めている。さらに、ポータブルFCGデバイスやAIシステムに接続されたECGガジェットを含む最先端のECGガジェットの導入は、市場拡大に拍車をかけると予想される。新しいモニタリング機器の発売とFCG機器の生産における進歩は、市場を前進させる理由の2つである。医療支出の増加と個人の可処分所得の増加が組み合わさったことも、欧州ECG市場の成長を促進する要因である。老いも若きも、食べ物の選択や不摂生な生活といったライフスタイルの変化により、心血管疾患が増加している。欧州における心血管疾患（CVD）の有病率の増加は、心電図用電極を含む医療機器の大きな需要につながっている。ECG電極市場は、同地域における心臓関連疾患の有病率の上昇に伴い、医療従事者や医療機関が正確な心臓モニタリングを提供するための先進技術を積極的に探している結果、成長している。欧州心臓病学会（European Society of Cardiology）によると、毎年約1,100万人が新たにCVDに罹患しており、同地域における死亡者数の45%を占めている。さらに、同地域におけるCVDの年間経済コストは2,200億米ドルを超えている。その結果、市場は拡大している。

Bonafide Research社の調査レポート「欧州の心電計（ECG）市場の展望、2028年」によると、欧州の心電計（ECG）市場は2023年から2028年にかけて8億米ドルの増加が見込まれている。より正確で効率的な分析のためにECG機器にAIを統合する傾向が強まっている。AIアルゴリズムは異常の早期発見を支援し、医療従事者に貴重な洞察を提供することができる。ECG市場では、継続的な技術進歩が大きなトレンドとなっている。これには、ポータブルおよびワイヤレスECG機器の開発が含まれ、患者が遠隔で心臓の健康状態をモニターすることがより便利になった。予防医療へのシフトが進んでおり、ECG機器は潜在的な心臓の問題を深刻化する前に特定する上で重要な役割を果たしている。この予防的アプローチは、医療費削減と患者の転帰改善を目指す広範な取り組みと一致している。ECGデータをデジタル・ヘルス・プラットフォームや電子カルテ（EHR）に統合することがトレンドとなっている。これにより、医療提供者間で患者情報をシームレスに共有できるようになり、ケアの継続性が向上する。ECG機器と統合するモバイル健康アプリケーションの普及は増加傾向にある。これらのアプリケーションは、心電図のモニタリングを容易にするだけでなく、実用的な洞察や健康上の推奨事項、医療提供者とのデータ共有機能をユーザーに提供する。医療提供における費用対効果や効率といった経済的な考慮が、市場動向の形成に一役買っている。医療提供者や医療システムは、質の高い患者ケアを維持しながら、コストに見合った価値を提供するソリューションをますます求めるようになっている。遠隔医療や遠隔患者モニタリングを取り巻く規制の枠組みは、ECG機器の採用に影響を与える。規制や償還方針の変更は、医療提供者がECG技術をどのようにサービス提供に組み込むかに影響を与える可能性がある。

市場はドイツ、英国、フランス、イタリア、スペイン、ロシアに分散している。ドイツは欧州最大の経済大国であり、世界でも有数の経済大国である。同国の経済力は、強固な医療インフラと高水準の医療支出に貢献し、ECG機器を含む先進医療技術の導入に有利な環境を育んでいる。ドイツは、技術革新に重点を置いた整備された高度な医療インフラを誇っている。同国の医療制度は高水準のケアを特徴としており、この卓越性へのコミットメントは最先端医療技術の採用にも及んでいる。ドイツの企業は、医療技術分野における研究開発の最前線に立つことが多い。ドイツには技術革新への投資の歴史があり、この研究開発へのコミットメントが、高度な機能と性能を備えた最先端のECG機器の開発を可能にしている。多くの先進国と同様、ドイツでも心血管疾患の蔓延は重大な健康問題である。心電図装置のような心血管疾患に対する正確で高度な診断ツールの必要性が、市場の需要を牽引している。さらに、スペインで医療費が増加すれば、ECG機器を含む先進医療技術への投資が拡大する可能性がある。医療インフラやサービスに対する資金が増加すれば、市場の成長に寄与する可能性がある。人口の高齢化はしばしば心血管疾患の罹患率の上昇につながる。スペインで高齢化に伴う人口動態の変化が起これば、ECG機器を含む心血管診断ツールの需要も相応に増加する可能性がある。

市場は製品別に、安静時心電計（ECG）、負荷心電計（ECG）、ホルターモニター、イベントレコーダー、その他に区分される。なかでも、安静時心電計（ECG）は欧州の心電計（ECG）市場をリードすると予想されている。安静時心電図は一般的に、標準的な健康診断や検査におけるルーチン診断に使用される。これらの検査は定期的な健康評価の一部であるため、安静時ECGはプライマリケアや外来患者における基本的なツールとなっている。安静時ECGは、冠動脈疾患や不整脈などの心血管疾患のスクリーニングにおいて重要な役割を果たす。欧州では心血管疾患の有病率が高いため、安静時の異常を効率的に検出できる診断ツールが常に求められている。安静時心電図は非侵襲的であり、施行も比較的容易である。手技が簡単なため、小児から高齢者まで幅広い患者に適しており、臨床現場での人気と普及に貢献している。安静時心電図は一般に、より複雑な診断手技と比較して費用対効果が高いと考えられている。そのため、初期評価やルーチンのスクリーニングで好まれることが多く、医療提供者にとって費用効率の高い選択肢となっている。安静時心電図は一般的に、定期健康診断やウェルネス・プログラムに含まれている。予防医療が重視されるようになったことで、定期的な心血管スクリーニングの需要が高まり、安静時ECGの使用をさらに後押ししている。欧州では高齢化が進んでおり、高齢者は定期的な心血管モニタリングが必要になることが多い。安静時心電図は、安静時の心臓の健康状態に関する貴重な洞察を提供し、加齢に関連する心血管系疾患の管理に役立つため、この層に適している。

エンドユーザー別に見ると、市場は病院＆クリニック、在宅環境＆外来手術センター（ASC）、その他に二分される。在宅ECGモニタリングは、慢性心血管系疾患を管理する個人にとって特に有益である。自宅での定期的なECG検査は、異常の早期発見に役立ち、タイムリーな介入を促進し、全体的な疾患管理を改善する。小型でワイヤレスのECG装置の開発など技術の進歩により、診断機能を家庭環境に導入することが現実的になってきた。これらの機器は、患者が最小限の労力で自己モニタリングを行えるよう、使いやすさを重視して設計されていることが多い。家庭用ECG装置は使いやすいように設計されており、患者が効果的に使用するためには最小限のトレーニングしか必要としない。操作が簡単であるため、定期的な使用が促され、継続的なモニタリングや潜在的な心臓疾患の早期発見が容易になる。ASCはしばしば、心電図検査を含む専門的な診断サービスを提供している。このような専門化により、これらのセンターは高品質の心臓血管診断とケアの提供に集中することができ、外来での専門知識を求める患者を引き付けることができる。ASCはしばしば当日の処置や検査を優先し、一晩入院する必要性を最小限に抑える。安静時心電図は短時間で非侵襲的な手技であるため、1回の外来受診でタイムリーな診断結果を提供するという傾向に合致している。欧州では外来手術センターの数が増加傾向にある。ASCの利用可能性とアクセシビリティが高まるにつれて、これらのセンターで心電図検査を受ける人が増える可能性があり、市場成長の原動力となっている。

最近の動向

- 2022年1月、フィリップスは分散型臨床試験向けの新しい在宅12誘導心電図ソリューションを発表した。このソリューションは、施設訪問の必要性を減らすことで、コンプライアンス、患者の募集および維持を改善するように設計されている。

- 2022年6月、AliveCor社は、30秒で医療グレードの心電図が得られるクレジットカードサイズの心電図装置KardiaMobile Cardを発表した。これは、FDAの認可を受けた世界初のクレジットカードサイズの心電図装置である。

- 2021年3月、Rhythmlink社は、1.5テスラおよび3テスラMRI環境における術中神経生理学的モニタリング（IONM）および脳波計（EEG）に使用される新しいスティッキーパッド表面電極のFDA認可を取得した。

- 2021年9月、Bittiumは新しいOmegaSnapパッチ電極を発売し、Bittium Faros ECGデバイスと互換性のある1-CH、2-CH、3-CH ECG測定を提供する。

本レポートの対象企業

Koninklijke Philips N.V.、GE HealthCare Technologies, Inc.、Midmark Corporation、Schiller AG、日本光電工業株式会社、Baxter International Inc.、Medline Industries、EDAN Instruments, Inc.、Bionet Co.Ltd.、フクダ電子株式会社、OSI Systems, Inc.、Mindray Medical International Limited.

本レポートで検討しているもの

- 地域北米
- 歴史的な年2017
- 基準年2022
- 推定年2023
- 予測年2028

本レポートでカバーされている側面

- 北米の心電計（ECG）市場の展望とその価値およびセグメント別の予測
- 国別の心電計（ECG）市場分析
- 様々な促進要因と課題
- 進行中のトレンドと開発
- 注目企業
- 戦略的推奨

レポート対象国

- ドイツ
- イギリス
- フランス
- イタリア
- スペイン
- ロシア

製品別

- 安静時心電計（ECG）
- 負荷心電計（ECG）
- ホルターモニター
- イベントレコーダー
- その他

エンドユーザー別

- 病院・クリニック
- 在宅医療・外来手術センター(ASC)
- その他

レポートのアプローチ

本レポートは一次調査と二次調査を組み合わせたアプローチで構成されている。当初は、市場を理解し、そこに存在する企業をリストアップするために二次調査が用いられた。二次調査は、プレスリリース、企業の年次報告書、政府が作成した報告書やデータベースなどの第三者情報源からなる。二次情報源からデータを収集した後、一次調査は、市場がどのように機能しているかについて主要プレーヤーに電話インタビューを行い、市場のディーラーやディストリビューターと取引コールを行うことによって実施された。その後、消費者を地域別、階層別、年齢層別、性別に均等にセグメンテーションし、一次調査を開始した。一次データを入手したら、二次ソースから得た詳細の検証を開始することができる。

対象読者

本レポートは、心電計（ECG）産業に関連する業界コンサルタント、メーカー、サプライヤー、団体、組織、政府機関、その他のステークホルダーが市場中心の戦略を調整するのに役立ちます。マーケティングやプレゼンテーションに加え、業界に関する競合知識を高めることもできます。





***注：ご注文確認後、報告書をお届けするまでに48時間（2営業日）かかります。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Research Methodology
2.1. Secondary Research
2.2. Primary Data Collection
2.3. Market Formation & Validation
2.4. Report Writing, Quality Check & Delivery
3. Market Structure
3.1. Market Considerate
3.2. Assumptions
3.3. Limitations
3.4. Abbreviations
3.5. Sources
3.6. Definitions
4. Economic /Demographic Snapshot
5. Global Electrocardiographic (ECG) Market Outlook
5.1. Market Size By Value
5.2. Market Share By Region
5.3. Market Size and Forecast, By Product
5.4. Market Size and Forecast, By End User
5.5. Market Size and Forecast, By Lead Type
5.6. Market Size and Forecast, By Technology
5.7. Market Size and Forecast, By Indication
6. Europe Electrocardiographic (ECG) Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product
6.4. Market Size and Forecast, By End User
6.5. Market Size and Forecast, By Indication
7. Market Dynamics
7.1. Market Drivers & Opportunities
7.2. Market Restraints & Challenges
7.3. Market Trends
7.4. Covid-19 Effect
7.5. Supply chain Analysis
7.6. Policy & Regulatory Framework
7.7. Industry Experts Views
7.8. Germany Electrocardiographic (ECG) Market Outlook
7.8.1. Market Size By Value
7.8.2. Market Size and Forecast By Product
7.8.3. Market Size and Forecast By End User
7.8.4. Market Size and Forecast By Indication
7.9. United Kingdom Electrocardiographic (ECG) Market Outlook
7.9.1. Market Size By Value
7.9.2. Market Size and Forecast By Product
7.9.3. Market Size and Forecast By End User
7.9.4. Market Size and Forecast By Indication
7.10. France Electrocardiographic (ECG) Market Outlook
7.10.1. Market Size By Value
7.10.2. Market Size and Forecast By Product
7.10.3. Market Size and Forecast By End User
7.10.4. Market Size and Forecast By Indication
7.11. Italy Electrocardiographic (ECG) Market Outlook
7.11.1. Market Size By Value
7.11.2. Market Size and Forecast By Product
7.11.3. Market Size and Forecast By End User
7.11.4. Market Size and Forecast By Indication
7.12. Spain Electrocardiographic (ECG) Market Outlook
7.12.1. Market Size By Value
7.12.2. Market Size and Forecast By Product
7.12.3. Market Size and Forecast By End User
7.12.4. Market Size and Forecast By Indication
7.13. Russia Electrocardiographic (ECG) Market Outlook
7.13.1. Market Size By Value
7.13.2. Market Size and Forecast By Product
7.13.3. Market Size and Forecast By End User
7.13.4. Market Size and Forecast By Indication
8. Competitive Landscape
8.1. Competitive Dashboard
8.2. Business Strategies Adopted by Key Players
8.3. Key Players Market Positioning Matrix
8.4. Porter's Five Forces
8.5. Company Profile
8.5.1. Koninklijke Philips N.V.
8.5.1.1. Company Snapshot
8.5.1.2. Company Overview
8.5.1.3. Financial Highlights
8.5.1.4. Geographic Insights
8.5.1.5. Business Segment & Performance
8.5.1.6. Product Portfolio
8.5.1.7. Key Executives
8.5.1.8. Strategic Moves & Developments
8.5.2. GE HealthCare Technologies, Inc.
8.5.3. Midmark Corporation
8.5.4. Schiller AG
8.5.5. Nihon Kohden Corporation
8.5.6. Baxter International Inc.
8.5.7. Medline Industries
8.5.8. EDAN Instruments, Inc.
8.5.9. Bionet Co., Ltd.
8.5.10. Fukuda Denshi Co Ltd
8.5.11. OSI Systems, Inc.
8.5.12. Mindray Medical International Limited
9. Strategic Recommendations
10. Annexure
10.1. FAQ`s
10.2. Notes
10.3. Related Reports
11. Disclaimer

List of Figures
Figure 1: Global Electrocardiographic (ECG) Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Electrocardiographic (ECG) Market Share By Region (2022)
Figure 6: Europe Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: Europe Electrocardiographic (ECG) Market Share By Country (2022)
Figure 8: Germany Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: UK Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: France Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Italy Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: Spain Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 13: Russia Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 14: Competitive Dashboard of top 5 players, 2022
Figure 15: Porter's Five Forces of Global Electrocardiographic (ECG) Market
 

List of Table
Table 1 : Global Electrocardiographic (ECG) Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2020
Table 3: Economic Snapshot of Other Prominent Countries 2020
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5 : Global Electrocardiographic (ECG) Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 6 : Global Electrocardiographic (ECG) Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 7 : Global Electrocardiographic (ECG) Market Size and Forecast, By Lead Type (2017 to 2028F) (In USD Billion)
Table 8 : Global Electrocardiographic (ECG) Market Size and Forecast, By Technology (2017 to 2028F) (In USD Billion)
Table 9 : Global Electrocardiographic (ECG) Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 10 : Europe Electrocardiographic (ECG) Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 11 : Europe Electrocardiographic (ECG) Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 12 : Europe Electrocardiographic (ECG) Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 13 : Influencing Factors for Electrocardiographic (ECG) Market, 2022
Table 14 : Germany Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 15 : Germany Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 16 : Germany Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 17 : United Kingdom Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 18 : United Kingdom Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 19 : United Kingdom Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 20 : France Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 21 : France Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 22 : France Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 23 : Italy Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 24 : Italy Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 25 : Italy Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 26 : Spain Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 27 : Spain Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 28 : Spain Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 29 : Russia Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 30 : Russia Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 31 : Russia Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)

　

ページTOPに戻る


　

Summary

In Europe Cardiologists use an electrocardiogram (ECG) to assess whether the electrical activity is fast, irregular, or normal. In order to determine whether the heart's components are overly big or overworked, it is also used to monitor the amount of electrical activity that flows through the heart muscle. An electrocardiogram (ECG) is a non-invasive medical test that records the heartbeat's electrical activity over time. An electrical impulse is produced by each heartbeat and is captured using electrodes. The electrodes pick up even the tiniest electrical fluctuations in the skin that result from the heart muscle depolarizing with each beating. According to the World Health Organisation, cardiovascular diseases account for the majority of deaths in Europe (WHO). Furthermore, the introduction of cutting-edge ECG gadgets including portable FCG devices and ECG gadgets connected to AI systems is anticipated to fuel market expansion. The launch of new monitoring devices and advancements in the production of FCG equipment are two of the reasons propelling the market forward. Increased healthcare spending combined with rising individual disposable income is another factor driving the growth of the European ECG market. Both young and old people are experiencing a rise in cardiovascular disease as a result of changing lifestyle factors like food choices and an inactive lifestyle. The increased prevalence of cardiovascular disease (CVD) in Europe has led to a significant demand for medical devices, including electrodes for electrocardiograms. The ECG electrode market is growing as a result of healthcare practitioners and institutions actively searching for advanced technologies to provide precise cardiac monitoring due to the rising prevalence of heart-related illnesses in the region. According to the European Society of Cardiology, about 11 million new cases of CVD are recorded each year, accounting for 45% of all fatalities in the region. Furthermore, the annual economic cost of CVD in the region surpasses USD 220 billion. The market is growing as a result.

According to the research report "Europe Electrocardiograph (ECG) Market Outlook, 2028," published by Bonafide Research, the Europe Electrocardiograph (ECG) market is anticipated to add USD 800 Million from 2023 to 2028. The integration of AI in ECG devices for more accurate and efficient analysis has been a growing trend. AI algorithms can assist in the early detection of abnormalities and provide healthcare professionals with valuable insights. Continuous technological advancements have been a significant trend in the ECG market. This includes the development of portable and wireless ECG devices, making it more convenient for patients to monitor their heart health remotely. There is a shift towards preventive healthcare, and ECG devices play a crucial role in identifying potential heart issues before they become more severe. This preventive approach aligns with broader efforts to reduce healthcare costs and improve patient outcomes. The integration of ECG data into digital health platforms and electronic health records (EHRs) has been a trend. This enables seamless sharing of patient information among healthcare providers and facilitates better continuity of care. The proliferation of mobile health applications that integrate with ECG devices has been on the rise. These apps not only facilitate ECG monitoring but also provide users with actionable insights, health recommendations, and the ability to share data with healthcare providers. Economic considerations, such as cost-effectiveness and efficiency in healthcare delivery, play a role in shaping market trends. Healthcare providers and systems are increasingly looking for solutions that offer value for money while maintaining high-quality patient care. Regulatory frameworks surrounding telemedicine and remote patient monitoring impact the adoption of ECG devices. Changes in regulations and reimbursement policies can influence how healthcare providers incorporate ECG technologies into their service offerings.

The market is spilt-up into Germany, United Kingdom, France, Italy, Spain and Russia. Germany is the largest economy in Europe and one of the leading economies globally. The country's economic strength contributes to robust healthcare infrastructure and high levels of healthcare spending, fostering a favorable environment for the adoption of advanced medical technologies, including ECG devices. Germany boasts a well-developed and advanced healthcare infrastructure with a strong emphasis on technological innovation. The country's healthcare system is characterized by a high standard of care, and this commitment to excellence extends to the adoption of cutting-edge medical technologies. German companies are often at the forefront of research and development in the medical technology sector. The country has a history of investing in innovation, and this commitment to R&D enables the development of state-of-the-art ECG devices with advanced features and capabilities. The prevalence of cardiovascular diseases is a significant health concern in Germany, as in many developed countries. The need for accurate and advanced diagnostic tools for cardiovascular conditions, such as ECG devices, drives demand in the market. Furthermore, If Spain experiences an increase in healthcare expenditure; it could lead to greater investment in advanced medical technologies, including ECG devices. A rise in funding for healthcare infrastructure and services may contribute to market growth. Ageing populations often lead to a higher incidence of cardiovascular diseases. If Spain experiences demographic shifts with an ageing population, there could be a corresponding increase in the demand for cardiovascular diagnostic tools, including ECG devices.

Based on Product the market is segmented into Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Holter Monitors, Event Recorders and Others. Among them Resting Electrocardiograph (ECG) is expected to leading the Europe Electrocardiograph (ECG) market. Resting ECGs are commonly used for routine diagnostics during standard medical check-ups and examinations. These tests are part of regular health assessments, making resting ECGs a fundamental tool in primary care and outpatient settings. Resting ECGs play a crucial role in screening for cardiovascular diseases, such as coronary artery disease and arrhythmias. Given the high prevalence of cardiovascular conditions in Europe, there is a consistent demand for diagnostic tools that can efficiently detect abnormalities during rest. Resting ECGs are non-invasive and relatively easy to administer. The simplicity of the procedure makes it suitable for a wide range of patients, from children to the elderly, contributing to its popularity and widespread use in clinical practice. Resting ECGs are generally considered cost-effective compared to more complex diagnostic procedures. As a result, they are often preferred in initial assessments and routine screenings, making them a cost-efficient option for healthcare providers. Resting ECGs are commonly included in routine health check-ups and wellness programs. The emphasis on preventive healthcare has increased the demand for regular cardiovascular screenings, further supporting the use of resting ECGs. Europe has an aging population, and older individuals often require regular cardiovascular monitoring. Resting ECGs are well-suited for this demographic, as they provide valuable insights into the heart's health during periods of rest, helping in the management of age-related cardiovascular conditions.

In terms of end user the market is bifurcated into Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs) and others. Home-based ECG monitoring is particularly beneficial for individuals managing chronic cardiovascular conditions. Regular ECG tests at home can aid in the early detection of abnormalities, facilitate timely interventions, and improve overall disease management. Advances in technology, including the development of compact and wireless ECG devices, have made it feasible to bring diagnostic capabilities into home settings. These devices are often designed for ease of use, allowing patients to perform self-monitoring with minimal effort. Home ECG devices are designed to be user-friendly, requiring minimal training for patients to use them effectively. The simplicity of operation encourages regular usage, facilitating continuous monitoring and early detection of potential cardiac issues. ASCs often offer specialized diagnostic services, including ECG testing. This specialization allows these centers to focus on providing high-quality cardiovascular diagnostics and care, attracting patients seeking expertise in outpatient settings. ASCs often prioritize same-day procedures and tests, minimizing the need for overnight hospital stay. Resting ECGs, being a quick and non-invasive procedure, align with the trend of providing timely diagnostic results within a single outpatient visit. The number of Ambulatory Surgical Centers in Europe has been on the rise. As the availability and accessibility of ASCs increase, so does the potential for more individuals to undergo ECG tests in these centers, driving market growth.

Recent Developments:

• In January 2022, Philips introduced a new at-home, 12-lead ECG solution for decentralized clinical trials. This solution is designed to improve compliance, patient recruitment and retention by reducing the need for site visits.

• In June 2022, AliveCor released the KardiaMobile Card, a credit-card-sized ECG device that provides a medical-grade ECG in 30 seconds. It is the world's first FDA-cleared credit-card-sized ECG device.

• In March 2021, Rhythmlink received FDA clearance for its new Sticky Pad Surface Electrodes, used for Intraoperative Neurophysiological Monitoring (IONM) and Electroencephalography (EEG) in 1.5 and 3 Tesla MRI environments.

• In September 2021, Bittium's launched new OmegaSnap patch electrodes offer 1-CH, 2-CH, and 3-CH ECG measurements compatible with the Bittium Faros ECG device

Companies Covered in this report:

Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Midmark Corporation, Schiller AG, Nihon Kohden Corporation, Baxter International Inc., Medline Industries, EDAN Instruments, Inc., Bionet Co., Ltd., Fukuda Denshi Co Ltd, OSI Systems, Inc., Mindray Medical International Limited.

Considered in this report

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• North America Electrocardiograph (ECG) market Outlook with its value and forecast along with its segments
• Country-wise Electrocardiograph (ECG) market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product

• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User

• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.





***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Research Methodology
2.1. Secondary Research
2.2. Primary Data Collection
2.3. Market Formation & Validation
2.4. Report Writing, Quality Check & Delivery
3. Market Structure
3.1. Market Considerate
3.2. Assumptions
3.3. Limitations
3.4. Abbreviations
3.5. Sources
3.6. Definitions
4. Economic /Demographic Snapshot
5. Global Electrocardiographic (ECG) Market Outlook
5.1. Market Size By Value
5.2. Market Share By Region
5.3. Market Size and Forecast, By Product
5.4. Market Size and Forecast, By End User
5.5. Market Size and Forecast, By Lead Type
5.6. Market Size and Forecast, By Technology
5.7. Market Size and Forecast, By Indication
6. Europe Electrocardiographic (ECG) Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product
6.4. Market Size and Forecast, By End User
6.5. Market Size and Forecast, By Indication
7. Market Dynamics
7.1. Market Drivers & Opportunities
7.2. Market Restraints & Challenges
7.3. Market Trends
7.4. Covid-19 Effect
7.5. Supply chain Analysis
7.6. Policy & Regulatory Framework
7.7. Industry Experts Views
7.8. Germany Electrocardiographic (ECG) Market Outlook
7.8.1. Market Size By Value
7.8.2. Market Size and Forecast By Product
7.8.3. Market Size and Forecast By End User
7.8.4. Market Size and Forecast By Indication
7.9. United Kingdom Electrocardiographic (ECG) Market Outlook
7.9.1. Market Size By Value
7.9.2. Market Size and Forecast By Product
7.9.3. Market Size and Forecast By End User
7.9.4. Market Size and Forecast By Indication
7.10. France Electrocardiographic (ECG) Market Outlook
7.10.1. Market Size By Value
7.10.2. Market Size and Forecast By Product
7.10.3. Market Size and Forecast By End User
7.10.4. Market Size and Forecast By Indication
7.11. Italy Electrocardiographic (ECG) Market Outlook
7.11.1. Market Size By Value
7.11.2. Market Size and Forecast By Product
7.11.3. Market Size and Forecast By End User
7.11.4. Market Size and Forecast By Indication
7.12. Spain Electrocardiographic (ECG) Market Outlook
7.12.1. Market Size By Value
7.12.2. Market Size and Forecast By Product
7.12.3. Market Size and Forecast By End User
7.12.4. Market Size and Forecast By Indication
7.13. Russia Electrocardiographic (ECG) Market Outlook
7.13.1. Market Size By Value
7.13.2. Market Size and Forecast By Product
7.13.3. Market Size and Forecast By End User
7.13.4. Market Size and Forecast By Indication
8. Competitive Landscape
8.1. Competitive Dashboard
8.2. Business Strategies Adopted by Key Players
8.3. Key Players Market Positioning Matrix
8.4. Porter's Five Forces
8.5. Company Profile
8.5.1. Koninklijke Philips N.V.
8.5.1.1. Company Snapshot
8.5.1.2. Company Overview
8.5.1.3. Financial Highlights
8.5.1.4. Geographic Insights
8.5.1.5. Business Segment & Performance
8.5.1.6. Product Portfolio
8.5.1.7. Key Executives
8.5.1.8. Strategic Moves & Developments
8.5.2. GE HealthCare Technologies, Inc.
8.5.3. Midmark Corporation
8.5.4. Schiller AG
8.5.5. Nihon Kohden Corporation
8.5.6. Baxter International Inc.
8.5.7. Medline Industries
8.5.8. EDAN Instruments, Inc.
8.5.9. Bionet Co., Ltd.
8.5.10. Fukuda Denshi Co Ltd
8.5.11. OSI Systems, Inc.
8.5.12. Mindray Medical International Limited
9. Strategic Recommendations
10. Annexure
10.1. FAQ`s
10.2. Notes
10.3. Related Reports
11. Disclaimer

List of Figures
Figure 1: Global Electrocardiographic (ECG) Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Electrocardiographic (ECG) Market Share By Region (2022)
Figure 6: Europe Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: Europe Electrocardiographic (ECG) Market Share By Country (2022)
Figure 8: Germany Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: UK Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: France Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Italy Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: Spain Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 13: Russia Electrocardiographic (ECG) Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 14: Competitive Dashboard of top 5 players, 2022
Figure 15: Porter's Five Forces of Global Electrocardiographic (ECG) Market
 

List of Table
Table 1 : Global Electrocardiographic (ECG) Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2020
Table 3: Economic Snapshot of Other Prominent Countries 2020
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5 : Global Electrocardiographic (ECG) Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 6 : Global Electrocardiographic (ECG) Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 7 : Global Electrocardiographic (ECG) Market Size and Forecast, By Lead Type (2017 to 2028F) (In USD Billion)
Table 8 : Global Electrocardiographic (ECG) Market Size and Forecast, By Technology (2017 to 2028F) (In USD Billion)
Table 9 : Global Electrocardiographic (ECG) Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 10 : Europe Electrocardiographic (ECG) Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 11 : Europe Electrocardiographic (ECG) Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 12 : Europe Electrocardiographic (ECG) Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 13 : Influencing Factors for Electrocardiographic (ECG) Market, 2022
Table 14 : Germany Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 15 : Germany Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 16 : Germany Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 17 : United Kingdom Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 18 : United Kingdom Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 19 : United Kingdom Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 20 : France Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 21 : France Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 22 : France Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 23 : Italy Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 24 : Italy Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 25 : Italy Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 26 : Spain Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 27 : Spain Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 28 : Spain Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 29 : Russia Electrocardiographic (ECG) Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 30 : Russia Electrocardiographic (ECG) Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 31 : Russia Electrocardiographic (ECG) Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

Bonafide Research & Marketing Pvt. Ltd. 社の最新刊レポート

本レポートと同じKEY WORD（ecg）の最新刊レポート


よくあるご質問


Bonafide Research & Marketing Pvt. Ltd.社はどのような調査会社ですか?


Bonafide Research & Marketing Pvt. Ltd.は、最新の経済、人口統計、貿易、市場データを提供する市場調査・コンサルティング会社です。調査レポート、カスタムレポート、コ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04　10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.